Memarzadeh S, Berek JS.Advances in the management of epithelial ovarian cancer. J Reprod Med. 2001;46:621-629.
2.
Fields AL, Jones JG, Thomas GM, Runowicz CD.Gynecology cancer. In: Lenhard RE Jr, Osteen RT, Gansler T, eds. Clincal Oncology. American Cancer Society.
3.
Lacey JV Jr, Mink PJ, Lubin JH, et al.Menopausal hormone replacement therapy and risk of ovarian cancer. JAMA. 2002;288:334-341.
4.
Baker VV.Treatment options for ovarian cancer. Clin Obstet Gynecol. 2001;44:522-530.
5.
Fung MF, Johnson ME, Eisenhauer EA, Elit L, Hirt HW, Rosen B.Chemotherapy for recurrent epithelial ovarian cancer previously treated with platinum—a systematic review of the evidence from randomized trials. Eur J Gynaecol Oncol. 2002;23:104-110.
6.
Gordon AN, Fleagle JT, Guthrie D, Parkin DE, Gore ME, Lacave AJ.Recurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus topotecan. J Clin Oncol. 2001;19:3312-3322.
